LAWRENCE, Mass., Aug. 24, 2017 /PRNewswire/ -- NxStage Medical, Inc. (Nasdaq: NXTM), a leading medical technology company focused on advancing renal care, today announced that the NxStage® System One™ ...
NxStage Medical, Inc.NXTM recently announced the regulatory approval of its System One platform by the FDA for solo home hemodialysis treatment. The company has also announced that it will provide ...
LAWRENCE, Mass., Aug. 28, 2017 /PRNewswire/ -- NxStage Medical, Inc. (Nasdaq: NXTM), a leading medical technology company focused on advancing renal care, today announced that the U.S. Food and Drug ...
SAN FRANCISCO (MarketWatch) -- NxStage Medical Inc. said late Wednesday it has received Food and Drug Administration 510(k) clearance to market its PureFlow SL product. This device is used to prepare ...
NxStage Medical Inc. of Lawrence has received U.S. Food and Drug Administration clearance to market its PureFlow SL product, a device that prepares high-purity dialysate from ordinary tap water in the ...
LAWRENCE, Mass., Aug. 4, 2017 /PRNewswire/ -- NxStage Medical, Inc. (Nasdaq: NXTM), a leading medical technology company focused on advancing renal care, joins over one hundred NxStage patients in ...
NxStage Medical, Inc.NXTM recently announced the receipt of CE mark for its NxGen Hemodialysis System, an innovative device with easier user interface and integrated blood pressure monitor system for ...
Home hemodialysis, particularly when delivered more frequently, is shown to significantly improve patients' quality-of-life and other important clinical outcomes. Because traditional in-center ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback